Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-103,047
Closed -$255K 3099
2025
Q1
$255K Buy
103,047
+92,678
+894% +$220K 0.01% 1530
2024
Q4
$32.6K Buy
+10,369
New +$50.2K ﹤0.01% 1967
2024
Q3
Sell
-43,300
Closed -$191K 2561
2024
Q2
$191K Buy
+43,300
New +$203K 0.02% 1257
2023
Q4
Sell
-12,401
Closed -$126K 2092
2023
Q3
$126K Buy
+12,401
New +$263K 0.02% 1147

Other funds holding SLRN

XTX Topco's SLRN Position: Q2 2025 in Review

XTX Topco sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 103,047 shares — an estimated $255K sold.

XTX Topco first reported a position in SLRN in Q3 2023 and held it in 4 quarters. The position peaked at $255K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • XTX Topco reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 103,047 ACELYRIN shares in Q2 2025, an estimated $255K.
  • XTX Topco first reported a position in ACELYRIN in Q3 2023 and held it in 4 quarters.
  • XTX Topco's ACELYRIN position peaked at $255K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.